The Gross Law Firm notifies investors that a class action has commenced in on behalf of shareholders of Teladoc Health, Inc. who purchased stock between November 2, 2022 and February 20, 2024.
According to the complaint, on February 20, 2024, Teladoc announced its fourth quarter and full year results for the period ended December 31, 2023. The announcement disclosed that Teladoc had experienced substantially less growth than previous forecasted. The Company also disclosed that it was expecting decreased revenue for its BetterHelp segment, an online counseling service. Analysts attributed this trend to BetterHelp’s market saturation and increased advertising costs causing a rise the cost of customer acquisitions. Following the release of the earnings report, TDOC shares fell $4.85/share, or 23.6%, overnight.
If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in the respective securities during the class periods. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action. Appointment as Lead Plaintiff is not required to partake in any recovery.
Shareholders have until July 16, 2024 to request that the court appoint them lead plaintiff.
To receive more information, please fill out the form.
